Floatz logo

INSULIN GLARGINE (SANOFI)

Hyperglycemia

The First Affiliated Hospital of Xiamen Universityprotein_peptidePhase 4 / ApprovedActive
B
63/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
48/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Hyperglycemia cohort.

Asset / SponsorPhaseRating
Humulin R
National Institute of Neurosciences and Hospital, Dhaka
Phase 4BBB
Metformin
The First Affiliated Hospital of Xiamen University
Phase 4BBB
Letrozole
Children's Hospital Los Angeles
Phase 4BB
Exenatide
Saint Luke's Health System
Phase 4BB
Olanzapine
Washington University School of Medicine
Phase 4BB

View all 31 →

Same molecule, other indications

INSULIN GLARGINE (SANOFI) is also rated in:

Diabetes Mellitus, Type 2Dormant
BB
Indicative ·
66 / 100
View asset →
Non-alcoholic Fatty Liver DiseaseDormant
B
Indicative ·
59 / 100
View asset →
Cardiovascular DiseasesDormant
B
Indicative ·
56 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →